# Xenetic Biosciences, Inc.: filings

XBIO · Nasdaq · CIK 1534525 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xbio.md) · [Financials](/companies/xbio/financials.md) · [Filings](/companies/xbio/filings.md) · [Insiders](/companies/xbio/insiders.md)

## Reports and events: 251 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 134, 4 70, 10-Q 44, CORRESP 29, 10-K/A 17, 3 17, S-1/A 17, 10-K 15, UPLOAD 14, 425 9, DEF 14A 9, EFFECT 9, 8-K/A 7, SC 13G 7, 424B5 6, NT 10-Q 6, 3/A 5, D 5, DEFA14A 5, S-3 5, SC 13G/A 5, S-8 4, 4/A 3, ARS 3, CT ORDER 3, NT 10-K 3, PRE 14A 3, S-1 3, SC 13D 3, SCHEDULE 13G 3, 424B3 2, 8-A12B 2, S-4/A 2, SC 13D/A 2, 25-NSE 1, 424B4 1, 8-A12B/A 1, CERT 1, CERTNAS 1, DEF 14C 1, DEFR14A 1, PRE 14C 1, S-3/A 1, S-4 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 17:20 ET | [8-K](/filings/0001683168-26-007340.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-007340 |
| 2026-09-16 | 07:00 ET | [8-K](/filings/0001683168-26-007181.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-007181 |
| 2026-08-07 | 08:35 ET | [8-K](/filings/0001683168-26-006077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-006077 |
| 2026-08-06 | 16:30 ET | [10-Q](/filings/0001683168-26-006061.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006061 |
| 2026-05-13 | 08:05 ET | [8-K](/filings/0001683168-26-003766.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-003766 |
| 2026-05-12 | 16:30 ET | [10-Q](/filings/0001683168-26-003727.md) | Quarterly report, period 2026-03-31 | 0001683168-26-003727 |
| 2026-04-24 | 17:15 ET | [10-K/A](/filings/0001683168-26-003207.md) | Annual report, amended, period 2025-12-31 | 0001683168-26-003207 |
| 2026-04-24 | 17:00 ET | [8-K](/filings/0001683168-26-003203.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-26-003203 |
| 2026-03-13 | 08:00 ET | [8-K](/filings/0001683168-26-001744.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-001744 |
| 2026-03-12 | 17:00 ET | [10-K](/filings/0001683168-26-001737.md) | Annual report, period 2025-12-31 | 0001683168-26-001737 |
| 2026-01-09 | 17:00 ET | [8-K](/filings/0001683168-26-000196.md) | 8.01 Other events | 0001683168-26-000196 |
| 2025-12-11 | 17:00 ET | [8-K](/filings/0001683168-25-009076.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-009076 |
| 2025-11-13 | 08:45 ET | [8-K](/filings/0001683168-25-008288.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-008288 |
| 2025-11-12 | 16:30 ET | [10-Q](/filings/0001683168-25-008259.md) | Quarterly report, period 2025-09-30 | 0001683168-25-008259 |
| 2025-10-31 | 16:10 ET | [DEF 14A](/filings/0001683168-25-007872.md) | Proxy statement, period 2025-12-11 | 0001683168-25-007872 |
| 2025-10-14 | 08:48 ET | [8-K](/filings/0001683168-25-007528.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-007528 |
| 2025-08-13 | 08:00 ET | [8-K](/filings/0001683168-25-006001.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-006001 |
| 2025-08-12 | 17:00 ET | [10-Q](/filings/0001683168-25-005983.md) | Quarterly report, period 2025-06-30 | 0001683168-25-005983 |
| 2025-05-14 | 08:27 ET | [8-K](/filings/0001683168-25-003513.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-003513 |
| 2025-05-13 | 17:00 ET | [10-Q](/filings/0001683168-25-003496.md) | Quarterly report, period 2025-03-31 | 0001683168-25-003496 |
| 2025-05-13 | 16:30 ET | [10-K/A](/filings/0001683168-25-003493.md) | Annual report, amended, period 2024-12-31 | 0001683168-25-003493 |
| 2025-04-29 | 17:00 ET | [10-K/A](/filings/0001683168-25-002939.md) | Annual report, amended, period 2024-12-31 | 0001683168-25-002939 |
| 2025-04-10 | 08:00 ET | [8-K](/filings/0001683168-25-002396.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-25-002396 |
| 2025-03-19 | 13:15 ET | [8-K/A](/filings/0001683168-25-001712.md) | 9.01 Financial statements and exhibits | 0001683168-25-001712 |
| 2025-03-19 | 08:05 ET | [8-K](/filings/0001683168-25-001693.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-001693 |
| 2025-03-18 | 16:30 ET | [10-K](/filings/0001683168-25-001686.md) | Annual report, period 2024-12-31 | 0001683168-25-001686 |
| 2024-12-13 | 16:30 ET | [8-K](/filings/0001683168-24-008712.md) | 5.07 Shareholder vote results | 0001683168-24-008712 |
| 2024-11-13 | 08:30 ET | [8-K](/filings/0001683168-24-007929.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-007929 |
| 2024-11-12 | 16:30 ET | [10-Q](/filings/0001683168-24-007903.md) | Quarterly report, period 2024-09-30 | 0001683168-24-007903 |
| 2024-11-07 | 09:00 ET | [8-K](/filings/0001683168-24-007710.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-007710 |
| 2024-10-31 | 17:00 ET | [8-K](/filings/0001683168-24-007527.md) | 5.02 Departure or appointment of officers or directors | 0001683168-24-007527 |
| 2024-10-31 | 16:30 ET | [DEF 14A](/filings/0001683168-24-007517.md) | Proxy statement, period 2024-12-11 | 0001683168-24-007517 |
| 2024-08-14 | 08:00 ET | [8-K](/filings/0001683168-24-005600.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-005600 |
| 2024-08-13 | 16:32 ET | [10-Q](/filings/0001683168-24-005572.md) | Quarterly report, period 2024-06-30 | 0001683168-24-005572 |
| 2024-06-21 | 16:30 ET | [8-K](/filings/0001683168-24-004415.md) | 5.02 Departure or appointment of officers or directors | 0001683168-24-004415 |
| 2024-05-22 | 17:00 ET | [8-K](/filings/0001683168-24-003779.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-003779 |
| 2024-05-10 | 08:30 ET | [8-K](/filings/0001683168-24-003192.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-003192 |
| 2024-05-09 | 17:00 ET | [10-Q](/filings/0001683168-24-003172.md) | Quarterly report, period 2024-03-31 | 0001683168-24-003172 |
| 2024-04-26 | 16:30 ET | [10-K/A](/filings/0001683168-24-002740.md) | Annual report, amended, period 2023-12-31 | 0001683168-24-002740 |
| 2024-03-22 | 08:00 ET | [8-K](/filings/0001683168-24-001606.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-001606 |
| 2024-03-21 | 17:00 ET | [10-K](/filings/0001683168-24-001594.md) | Annual report, period 2023-12-31 | 0001683168-24-001594 |
| 2024-03-18 | 13:45 ET | [SC 13D/A](/filings/0001213900-24-023384.md) | Ownership report, active investor, amended | 0001213900-24-023384 |
| 2024-02-12 | 09:15 ET | [8-K](/filings/0001683168-24-000866.md) | 7.01 Regulation FD disclosure | 0001683168-24-000866 |
| 2023-12-08 | 17:00 ET | [8-K](/filings/0001683168-23-008731.md) | 5.07 Shareholder vote results | 0001683168-23-008731 |
| 2023-11-13 | 17:00 ET | [DEF 14A](/filings/0001683168-23-007992.md) | Proxy statement, period 2023-12-06 | 0001683168-23-007992 |
| 2023-11-13 | 08:30 ET | [8-K](/filings/0001683168-23-007922.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-007922 |
| 2023-11-09 | 17:00 ET | [10-Q](/filings/0001683168-23-007820.md) | Quarterly report, period 2023-09-30 | 0001683168-23-007820 |
| 2023-09-18 | 12:21 ET | [SC 13D/A](/filings/0001213900-23-077250.md) | Ownership report, active investor, amended | 0001213900-23-077250 |
| 2023-08-11 | 08:05 ET | [8-K](/filings/0001683168-23-005538.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-005538 |
| 2023-08-10 | 16:30 ET | [10-Q](/filings/0001683168-23-005513.md) | Quarterly report, period 2023-06-30 | 0001683168-23-005513 |

Page 1 of 6. [Older](/companies/xbio/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.